The 28th Annual Meeting of the Chinese Biopharmaceutical Association (CBA) was successfully held on September 30, 2023, at the Marriott Washingtonian Center in Maryland. We extend our heartfelt thanks to all of you for delivering an exceptional annual feast for professionals in the biotech industry. 

The conference was absolutely outstanding, especially the highly anticipated Parallel Luncheon Session A, which was hosted by Mr. Gengcheng (Jack) Yang, Senior Director of Business Development at WuXi AppTec. During this prestigious event, Mr. Yang began by expressing his heartfelt gratitude to all the sponsors for their unwavering support of the Chinese Biopharmaceutical Association (CBA).

Subsequently, Mr. David Kolodny, representing Chanshow-biotech's American subsidiary, took the stage to provide an overview of the company. He emphasized the exceptional performance and underlying principles of the company's laboratory consumables in terms of low protein and nucleic acid adhesion, as well as its remarkable global supply capabilities. Furthermore, he highlighted the company's possession of nearly 8000 square meters of standardized manufacturing facilities, 100,000-level cleanrooms, and an exceptionally stringent quality control system.

This luncheon session presented a unique opportunity for attendees to gain deeper insights into the latest developments in the industry and to recognize the outstanding contributions of remarkable enterprises. The CBA Annual Meeting once again showcased its commitment to excellence and the high quality of its events.